INS and cancer: Furthermore, it has also been reported in non-diabetic and non-obese subjects that Hyperin itself is related to increased cancer deaths, and therefore the authors underline that a treatment to reduce circulating insulin levels could be an important therapeutic approach for the prevention of cancer [48,53].